ShareValue scores for SRT3.XETRA: Valuation 26, Quality 44, Growth 40, Health 29.

SRT3.XETRA
XETRA

Sartorius Aktiengesellschaft

€229.50(+0.26%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-10% to 9%
Valuation
26
Overvalued
Price vs Value
Quality
44
Moderate
Business Strength
Growth
40
Moderate
Revenue & Earnings
Health
29
Stressed
Financial Stability
Momentum
47
Neutral
Price Trend

Company Details

About

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026